Abstract
Introduction/BackgroundAdvanced Endometrial Cancer (EC) has limited therapeutic strategies after failure of first line, with 5-year survival rate of 18%. Approximately 30% of these tumors are microsatellite instability-high (MSI-H) or mismatch...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have